Suppr超能文献

第三天胚胎形态可预测老年受试者的整倍体情况。

Day-3 embryo morphology predicts euploidy among older subjects.

作者信息

Moayeri Sharon E, Allen Rene B, Brewster Wendy R, Kim Moon H, Porto Manuel, Werlin Lawrence B

机构信息

Department of Obstetrics and Gynecology, Stanford University Medical Center, Stanford, California 94305, USA.

出版信息

Fertil Steril. 2008 Jan;89(1):118-23. doi: 10.1016/j.fertnstert.2007.01.169. Epub 2007 Apr 23.

Abstract

OBJECTIVE

To evaluate whether day-3 embryo morphology predicts euploidy.

DESIGN

Retrospective.

SETTING

Private IVF center.

PATIENT(S): Subjects (n = 144) undergoing in vitro fertilization and preimplantation genetic diagnosis (PGD).

INTERVENTION(S): Translate day-3 embryo characteristics into a standardized score.

MAIN OUTCOME MEASURE(S): Day-3 embryo morphology score and PGD fluorescence in situ hybridization results for chromosomes: 13, 15, 16, 17, 18, 21, 22, X, and Y.

RESULT(S): Of 1,043 biopsied blastomeres, 67% (n = 696) were chromosomally abnormal. Women with advanced maternal age (AMA) were 1.3 times more likely to have chromosomal errors (95% CI 1.1-1.4) than younger subjects (<38 years old). Morphology predicted PGD results in the AMA group (n = 553), but not in younger women. Fragmentation predicted euploidy in both the younger and the AMA group, but cell number did not.

CONCLUSION(S): Day-3 embryo morphology selects for euploidy among AMA subjects but not among younger women who may have other factors responsible for embryo dysmorphism. However, cellular fragmentation is a sensitive proxy for selecting chromosomally normal embryos in both age groups. It is unclear that PGD-aneuploidy screening is a better tool for selecting which embryos to transfer than the standard approach of using day-3 embryo features, particularly among older women, a group for whom this technology is targeted.

摘要

目的

评估第三天胚胎形态是否能预测整倍体状态。

设计

回顾性研究。

地点

私立体外受精中心。

患者

接受体外受精和植入前基因诊断(PGD)的受试者(n = 144)。

干预措施

将第三天胚胎特征转化为标准化分数。

主要观察指标

第三天胚胎形态评分以及针对染色体13、15、16、17、18、21、22、X和Y的PGD荧光原位杂交结果。

结果

在1043个活检的卵裂球中,67%(n = 696)染色体异常。高龄产妇(AMA)出现染色体错误的可能性是年轻受试者(<38岁)的1.3倍(95%可信区间1.1 - 1.4)。形态学在AMA组(n = 553)中可预测PGD结果,但在年轻女性中则不然。碎片率在年轻组和AMA组中均可预测整倍体状态,但细胞数量则不能。

结论

第三天胚胎形态在AMA受试者中可筛选出整倍体胚胎,但在可能存在其他导致胚胎发育异常因素的年轻女性中则不能。然而,细胞碎片率是两个年龄组中筛选染色体正常胚胎的敏感指标。尚不清楚PGD非整倍体筛查作为选择移植胚胎的工具是否比使用第三天胚胎特征的标准方法更好,特别是在该技术所针对的老年女性中。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验